Loading…

Medical Research Finder

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Colitis / Intestinal Inflammation & Interleukin-23 (IL-23)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Chronic inflammatory disorders such as inflammatory bowel diseases (Crohn’s disease, ulcerative colitis) are caused by lymphocytes that are inappropriately activated and destroy self-tissues. Recent data have assigned a disease-promoting role to Interleukin-23 (IL-23), a cytokine of the Interleukin-12 (IL-12) family
Duerr et al. 2006 Science 314: 1461-1463
Izcue et al. 2009 Annu Rev Immunol 27: 313-338

IL-23 Deﬁciency or blockade protects from human [IBD](brain://Npyo13gOo0idTQuOpA…

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Duerr et al. 2006 Science 314: 1461-1463
Characterization of FOXP3 + CD4 + Treg cells in Crohn’s disease
Saruta et al. 2007 Clin. Immunol. 125: 281–90
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis
Kullberg et al. 2006 J Exp Med 203: 2485-2494
IL-23/IL-17 immunity as a hallmark of Crohn’s disease.
Hölttä et al. 2008 Inﬂamm. Bowel Dis. 14: 1175–84
Increased expression of interleukin 17 in inﬂammatory bowel disease
Fujino et al. 2003 Gut 52: 65–70
Interleukin-23 drives innate and T cell-mediated intestinal inflammation
Hue et al. 2006 J Exp Med 203: 2473-2483
Regulatory lymphocytes and intestinal inflammation
Izcue et al. 2009 Annu Rev Immunol 27: 313-338
Review

12/16/2025